[HTML][HTML] Diagnosis and treatment of chronic myelomonocytic leukemia

J Kwon - Blood research, 2021 - synapse.koreamed.org
… ) along with atypical chronic myeloid leukemia (CML), juvenile myelomonocytic leukemia,
MDS/… as a variable to the previously proposed cytogenetic-based risk prediction model [5, 6]. …

Diagnosis and treatment of chronic myeloid leukemia

CA Schiffer - Neoplastic Diseases of the Blood, 2018 - Springer
… Interestingly, although most cytogenetic responses were partial, a small fraction of
interferon-treated patients achieved persistent complete cytogenetic responses. This combination …

Current trends in molecular diagnostics of chronic myeloid leukemia

R Vinhas, M Cordeiro, P Pedrosa… - Leukemia & …, 2017 - Taylor & Francis
… [Citation3] Since then, there has been a steady evolution of the strategies for laboratory
diagnostics of CML, from cytogenetics to molecular characterization that support …

Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations

P Baliakas, B Espinet, C Mellink, M Jarosova… - …, 2022 - journals.lww.com
… In conclusion, cytogenetic analysis is not yet mature enough to guide treatment choices in
CLL. That notwithstanding, ERIC encourages the wide application of CBA, and potentially also …

[HTML][HTML] Diagnosis and treatment of chronic myelomonocytic leukemias in adults: recommendations from the European Hematology Association and the European …

R Itzykson, P Fenaux, D Bowen, NCP Cross… - …, 2018 - journals.lww.com
… the diagnosis of any type of CMML. The latter is important to differentiate CMML from atypical
chronic myeloid leukemia (… Cytogenetic analysis is mandatory in the diagnostic work-up of …

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

NCP Cross, T Ernst, S Branford, JM Cayuela… - Leukemia, 2023 - nature.com
… role in the initial diagnosis of CML by direct detection of the t(9;22)(… diagnostic tools in
patients with a clinical suspicion of CML, with cytogenetic follow up for confirmation and detection

Atypical chronic myeloid leukemia: new developments from molecular diagnosis to treatment

A Castellino, E Santambrogio, D Rapezzi, M Massaia - Medicina, 2021 - mdpi.com
Atypical Chronic Myeloid Leukemia, BCR-ABL1 negative (aCML) is a rare hematological
entity, included in the group of myelodysplastic (MDS)/myeloproliferative (MPN) overlap …

[HTML][HTML] Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review

MM Sampaio, MLC Santos, HS Marques… - World journal of …, 2021 - ncbi.nlm.nih.gov
… , Philadelphia chromosome, Diagnosis Core Tip: Chronic myeloid leukemia is a clonal
hematopoietic stem … The cytogenetics assists in the differential diagnosis with chronic neutrophilic …

Molecular monitoring of chronic myeloid leukemia: present and future

CCS Yeung, D Egan, JP Radich - … review of molecular diagnostics, 2016 - Taylor & Francis
… Various levels of cytogenetic response are determined by marrow metaphase
chromosome analysis (using a minimum requirement of ≥20 metaphases to be analyzed) [Citation16]. …

Acute myeloid leukemia: advancements in diagnosis and treatment

MG Yu, HY Zheng - Chinese medical journal, 2017 - mednexus.org
… Among all subtypes, a lack of consensus exists regarding the diagnosis and treatment of
acute myeloid leukemia (AML). Patient survival rates have remained modest for the past three …